Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, NE, USA.
Division of Hospital Medicine, University of Kentucky, Lexington, KY, USA.
Cardiovasc Revasc Med. 2022 Jul;40:92-98. doi: 10.1016/j.carrev.2021.11.026. Epub 2021 Nov 26.
Out-of-hospital cardiac arrest (OHCA) has a poor prognosis. The timing and role of early coronary angiography (CAG) in OHCA patients without ST elevation remains unclear.
We performed a meta-analysis of randomized controlled trials (RCTs) that compared early CAG to delayed CAG in OHCA patients without ST elevation.
We searched PubMed, Cochrane, and ClinicalTrials.gov databases (from inception to September 2021) for studies comparing early CAG to delayed CAG in OHCA patients without ST elevation. We used a random-effect model to calculate relative ratio (RR) with 95% confidence interval (CI). The primary outcome was all-cause mortality at 30 days. Secondary outcomes included neurological status with cerebral performance category ≤2 (CPC) and the rate of percutaneous coronary intervention (PCI) following CAG.
A total of 6 RCTs including 1822 patients, of whom 895 underwent early CAG, and 927 underwent delayed CAG, were included in this meta-analysis. There was no statistically significant difference between the 2 groups in terms of 30-day all-cause mortality (Relative risk [RR] 1.06; 95%CI 0.94-1.20; P = 0.32; I = 13%), neurological status (CPC ≤2) (RR 1.01; 95%CI 0.90-1.13; P = 0.85, I = 37%), and rates of PCI following CAG (RR 1.08; 95%CI 0.84-1.39; P = 0.56; I = 49%).
In patients suffering OHCA without ST-elevation, early CAG is not associated with reduced 30-day mortality when compared to patients who underwent delayed CAG. Given our meta-analysis results including multiple trials that have not shown a benefit, it is likely that updated guidelines will not support early angiography in patients suffering OHCA without ST-elevation.
院外心脏骤停(OHCA)的预后较差。对于无 ST 段抬高的 OHCA 患者,早期冠状动脉造影(CAG)的时机和作用仍不清楚。
我们对比较无 ST 段抬高的 OHCA 患者早期 CAG 与延迟 CAG 的随机对照试验(RCT)进行了荟萃分析。
我们检索了 PubMed、Cochrane 和 ClinicalTrials.gov 数据库(从建库到 2021 年 9 月),以比较无 ST 段抬高的 OHCA 患者早期 CAG 与延迟 CAG。我们使用随机效应模型计算相对比值(RR)及其 95%置信区间(CI)。主要结局是 30 天全因死亡率。次要结局包括神经功能状态(CPC≤2)和 CAG 后经皮冠状动脉介入治疗(PCI)的发生率。
共纳入 6 项 RCT,包括 1822 例患者,其中 895 例行早期 CAG,927 例行延迟 CAG。两组 30 天全因死亡率(RR 1.06;95%CI 0.94-1.20;P=0.32;I=13%)、神经功能状态(CPC≤2)(RR 1.01;95%CI 0.90-1.13;P=0.85,I=37%)和 CAG 后 PCI 发生率(RR 1.08;95%CI 0.84-1.39;P=0.56;I=49%)差异均无统计学意义。
对于无 ST 段抬高的 OHCA 患者,与延迟 CAG 相比,早期 CAG 并不能降低 30 天死亡率。鉴于包括多项未显示获益的试验在内的我们的荟萃分析结果,更新后的指南可能不支持对无 ST 段抬高的 OHCA 患者进行早期血管造影。